Reference health
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
44/44 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 44 checked references that resolve
resolves10.1056/NEJMoa2101765
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
resolves10.1136/annrheumdis-2021-220272
Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
resolves10.1136/annrheumdis-2021-220289
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
resolves10.1136/annrheumdis-2021-220231
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
resolves10.1002/art.27584
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
resolves10.1002/art.21972
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
resolves10.1136/ard.2009.108233
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
resolves10.1002/art.1780400928
Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
resolves10.1002/art.34473
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
resolves10.1136/annrheumdis-2017-211468
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
resolves10.1002/jmv.26605
Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects
resolves10.1186/s13075-015-0663-9
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
resolves10.1093/rheumatology/kei193
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
resolves10.1002/art.30580
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
resolves10.1136/ard.2011.152983
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice
resolves10.1002/acr.22246
Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis
resolves10.1136/annrheumdis-2017-211128
Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
resolves10.1136/annrheumdis-2018-213222
Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial
resolves10.1136/ard.2005.036434
Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockers
resolves10.1016/j.semarthrit.2008.12.002
The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
resolves10.3899/jrheum.130945
Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
resolves10.1136/rmdopen-2019-001035
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
resolves10.1136/annrheumdis-2012-201950
Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
resolves10.3109/14397595.2013.843743
Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab
resolves10.1186/ar4358
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
resolves10.1136/rmdopen-2019-001018
Secukinumab does not impair the immunogenic response to the influenza vaccine in patients
resolves10.1016/j.vaccine.2019.10.081
Immunogenicity and safety of vaccination against seasonal influenza vaccine in patients with psoriatic arthritis treated with secukinumab
resolves10.1136/annrheumdis-2014-207191
The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
resolves10.1186/s13075-019-1883-1
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy
resolves10.1002/art.25034
Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
resolves10.1002/art.25033
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
resolves10.1111/cei.12390
Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients
resolves10.1212/WNL.0000000000010380
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis
resolves10.1007/s10875-012-9813-x
Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
resolves10.1136/annrheumdis-2021-220604
Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
resolves10.1016/j.cell.2020.05.015
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
resolves10.1186/s12891-016-1082-z
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
resolves10.1016/j.healun.2021.04.003
BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response
resolves10.1016/j.jdcr.2021.04.014
Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases
resolves10.1111/jocd.14035
Herpes zoster following inactivated COVID‐19 vaccine: A coexistence or coincidence?
The 3 references without a DOI — listed, not checked
no DOI — not checkedForce D,. COVID-19 vaccine clinical guidance summary for patients with rheumatic and musculoskeletal diseases.
no DOI — not checkedFurer V, Zisman D, Kibari A,. Herpes zoster following BNT162b2 mRNA Covid-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series. Rheumatology.
no DOI — not checkedReduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220647"><img src="https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220647/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1136/annrheumdis-2021-220647)